Tip-flexible Semi-rigid Ureterorenoscope Versus Flexible Ureteroscopy in

Status Not yet recruiting

Clinical Trial Summary

This study evaluates the safety and efficacy of the novel tip-flexible semi-rigid ureterorenoscope for the treatment of renal calculi using a prospective, randomized multicentre trial design. Half of participants will receive retrograde intrarenal surgery using the tip-flexible semi-rigid ureterorenoscope, while the other half participants will receive retrograde intrarenal surgery using the classic flexible ureteroscope.

Clinical Trial Description

Retrograde intrarenal surgery using flexible ureteroscope has become the first-line treatment for renal calculi < 3.0 cm and is recommended by the European Association of Urology due to its minimally-invasive nature and satisfactory result.

However, some limitations still remain. Poor maneuverability, extra costs for the ureteral access sheath, and high device vulnerability still preclude flexible ureteroscopy from wider distribution.

Recently, the investigators present a novel ureterorenoscope, which is composed of a retractable rigid sheath and a semi-rigid ureteroscope with a flexible part on the tip. When the flexible tip of the inner shaft maintains within the sheath, working in the "rigid mode", the tip-flexible semi-rigid ureterorenoscope is capable of passing either the orifice or the physiological tortuosity of the ureter with ease. When the inner shaft is extended beyond the sheath, the endoscope is switched to the "flexible mode", capable of performing an intrarenal approach.

This endoscope integrates the classic semi-rigid and flexible ureteroscope both structurally and functionally, and has been approved for clinical application by the China Food and Drug Administration. In this study, transverse comparison is designed to evaluate the safety and efficacy of the tip-flexible semi-rigid ureterorenoscope for the treatment of renal calculi. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02426931
Study type	Interventional
Source	Changhai Hospital
Contact	Ling Li, MD
Phone	086-18019766513
Email	ejdll@163.com
Status	Not yet recruiting
Phase	N/A
Start date	April 2015
Completion date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01450566` - Intraureteral Lidocaine for Post-Ureteroscopy Pain	N/A
Recruiting	`NCT05701098` - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)	N/A
Not yet recruiting	`NCT01008267` - Shockwave Lithotripsy (SWL) Under Selective, General Anesthesia.	N/A
Completed	`NCT00250406` - Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation	Phase 2
Recruiting	`NCT00169806` - Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis	N/A
Not yet recruiting	`NCT02734914` - Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure	N/A
Completed	`NCT00169741` - Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC	N/A
Recruiting	`NCT05972408` - Evaluation of Prevalence, Molecular and Genetic Backgrounds of Calcium-Based Stones Among Patients With Renal Calcular Disease in Mansoura Urology and Nephrology Center	N/A
Enrolling by invitation	`NCT02408211` - Preoperative Antibiotic PNL Study	Phase 4
Completed	`NCT01437904` - A Pilot Study Assessing The Feasibility Of Outpatient Tubeless Percutaneous Nephrolithotomy (PCNL)	N/A
Completed	`NCT00857090` - Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones	Phase 1/Phase 2
Recruiting	`NCT05240170` - RIRS for Treatment of Stones in Congenital Anomalous Kidneys	N/A
Completed	`NCT03112499` - The Effect of Three Endourological Procedures for the Management of Renal Calculi Regarding Acute Kidney Injury	N/A
Recruiting	`NCT03206515` - The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones	N/A
Completed	`NCT03344107` - Stent-related Symptoms Comparison: Polaris Loop vs Vortek Double-J Stents	N/A
Recruiting	`NCT05077007` - Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers	N/A
Completed	`NCT03614247` - Cost-Effectiveness of Different Treatment Options for Lower Calyceal Stones	N/A
Recruiting	`NCT05739812` - The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery	N/A
Recruiting	`NCT05869890` - Ureteroscopic Laser Modality on Total Lasing Time and Total Energy in Patients With Large, Dense Renal Calculi	N/A
Completed	`NCT00893282` - Clinical Evaluation of BackStop in Patients Undergoing Intraureteric Stone Lithotripsy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Tip-flexible Semi-rigid Ureterorenoscope Versus Flexible Ureteroscopy in Renal Calculi

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms